IRIS
ZOPPOLI, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.968
AS - Asia 96
SA - Sud America 17
NA - Nord America 3
Totale 15.084
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.967
CN - Cina 79
BR - Brasile 11
SG - Singapore 9
VN - Vietnam 8
AR - Argentina 3
US - Stati Uniti d'America 3
EC - Ecuador 2
CL - Cile 1
FI - Finlandia 1
Totale 15.084
Salva come PNG Salva come JPEG
Città #
Genova 7.149
Genoa 5.415
Rapallo 1.330
Vado Ligure 1.037
Bordighera 36
Beijing 29
Singapore 6
Ashburn 3
Hanoi 2
Abreu e Lima 1
Anápolis 1
Aparecida de Goiânia 1
Belo Horizonte 1
Buenos Aires 1
Castanhal 1
Cuenca 1
Diamantina 1
Durán 1
Haiphong 1
Ho Chi Minh City 1
Ingeniero Maschwitz 1
Lappeenranta 1
Maipú 1
Novo Hamburgo 1
Phú Thọ 1
Posadas 1
Quixadá 1
Recife 1
Rio de Janeiro 1
Santa Bárbara 1
Vĩnh Long 1
Totale 15.029
Salva come PNG Salva come JPEG
Nome #
A modular framework for the development of targeted Covid-19 blood transcript profiling panels 303
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 225
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 218
P-334 * Radiological assessments for select patients in neoadjuvant setting in rectal cancer: monoinstitutional experience 218
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 216
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 205
APO866 activity in hematologic malignancies: a preclinical in vitro study. 204
A novel Bim-BH3-derived Bcl-X(L) inhibitor: Biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity 197
DNA aneuploidy relationship with patient age and tobacco smoke in OPMDs/OSCCs 192
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 187
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 181
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 179
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 178
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 177
Ras-induced resistance to lapatinib is overcome by MEK inhibition 175
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 174
Genomic DNA copy number aberrations, histological diagnosis, oral subsite and aneuploidy in OPMDs/OSCCs 174
Lymph node number, surface area and lymph node ratio are important prognostic indicators in neoadjuvant chemoradiotherapy treated rectal cancer 174
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. 166
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 166
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 163
Abstract 986: Unraveling breast cancer progression through geographical and temporal sequencing 161
Uncovering the genomic heterogeneity of multifocal breast cancer 160
Squalene epoxidase as a promising metabolic target in cancer treatment 158
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 158
The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer 156
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 153
Abstract A120: Cellular inhibition of Chk2 kinase and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 152
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases 151
Abstract 4693: The putative DNA/RNA Helicase Schlafen-11 sensitizes cancer cells to topoisomerase I inhibitors 148
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 147
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 146
Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic 146
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 145
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 143
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 143
Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions. 142
Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: Use Troponin Wisely 141
The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer. 140
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis. 136
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 136
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 136
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer 135
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents 134
Abstract CT075: Fasting-mimicking diet and hormone therapy modulates metabolic factors to promote breast cancer regression and reduce side effects 134
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 132
CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute. 131
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study 130
Abstract S2-05: Characterization and clinical relevance of the genomic alterations defining lobular breast cancer: 129
Correction to: Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer (Breast Cancer Research and Treatment, (2019), 10.1007/s10549-019-05313-w) 129
Genomic Characterization of Primary Invasive Lobular Breast Cancer 128
Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes. 128
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 127
Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. 127
DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment. 125
Monotherapy with Pegylated Interferon Alpha-2a in Hemodialyzed Patients with Chronic Hepatitis C 125
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 124
Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer. 122
Identification of a predominant co-regulation among kinetochore genes, prospective regulatory elements, and association with genomic instability. 122
Abstract 2116:CHEK2(Chk2) endogenous activation is associated with p53 deficiency and downregulation ofBRCA2and Fanconi Anemia pathway gene members in the National Cancer Institute Anticancer Tumor Cell Line Panel (NCI-60) 121
OMEGA (Offline Mutation Easy Genetic Annotator), a software analysis pipeline designed for thorough and easy annotation of NGS output 120
Coordinated regulation of mitochondrial topoisomerase IB with mitochondrial nuclear encoded genes and MYC. 120
Dynamic simulations of pathways downstream of TGF-beta , Wnt and EGF-family growth factors, in colorectal cancer, including mutations and treatments with onco-protein inhibitors 118
The role of sentinel lymph node biopsy in patients with B5C breast cancer diagnosis 117
Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer 117
Genomic aberrations in young and elderly breast cancer patients 116
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. 114
Development of a predictor of one-year mortality in older patients with cancer by geriatric and oncologic parameters 114
Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 113
Safety and feasibility of fasting‐mimicking diet and effects on nutritional status and circulating metabolic and inflammatory factors in cancer patients undergoing active treatment 113
Transcriptomic and genomic features of invasive lobular breast cancer 111
Gynaecomastia: the anastrozole paradox 111
Pre-operative and pathologic assessment in neoadjuvant setting for rectal cancer: the experience of "RECOM Group". 110
Longer intervals after neoadjuvant therapy in locally advanced rectal cancer: a monocentric experience 109
Development of a hoRizontal data intEgration classifier for NOn-invasive early diAgnosis of breasT cancEr: the RENOVATE study protocol 107
On biomarkers and pathways in rectal cancer: What's the target? 106
Impaired Humoral Response to Influenza Vaccine and Prolonged B Memory Cell Depletion as a Consequence of Rituximab-based Immunochemotherapy in non-Hodgkin Lymphoma Patients 106
Paralytic ileus and liver failure-an unusual presentation of advanced erythropoietic protoporphyria 106
Schlafen 11 Assessment in High-Grade Serous Ovarian Carcinoma: Phenotypic and Histological Distribution 106
Immune Infiltration in Invasive Lobular Breast Cancer 105
Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma 105
Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes. 102
Mutational analysis of BRCA1 and BRCA2 genes in high grade serous ovarian carcinoma with Next Generation Sequencing (NGS); correlation between somatic and germline mutations 100
Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature Review 100
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers 100
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 98
null 94
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer 92
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age 90
Purpura as the initial presentation for small-cell lung cancer 88
Standard Anthracycline-based versus Docetaxel-Capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/ BIG 3-04 MINDACT phase III trial 87
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 86
Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective 84
Radiological assessment for select patients in neoadjuvant setting in rectal cancer: monoinstitutional experience 79
Sterol synthesis pathway inhibition as a target for cancer treatment 79
Transcriptome Sequencing Of The Transition From Normal Epithelium To Invasive Cancer Reveals Insights Into The Carcinogenesis Of Hpv+ And Hpv- Vulvar Neoplasia 78
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative 78
Assessment of circulating nucleic acids in cancer: From current status to future perspectives and potential clinical applications 77
Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: a critical review of the literature for the RENOVATE study protocol 76
An integrated tumor, immune and microbiome atlas of colon cancer 75
Totale 13.480
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.704
article - articoli 50.971
book - libri 0
conference - conferenze 882
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 851
Totale 105.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021797 0 0 0 99 130 68 44 86 85 114 95 76
2021/20221.393 62 75 110 177 72 91 71 302 80 132 71 150
2022/20231.632 161 165 13 181 257 208 26 131 253 7 206 24
2023/20241.050 42 123 24 126 96 198 44 84 53 35 70 155
2024/20253.226 139 173 74 204 305 306 283 528 94 119 450 551
2025/20262.145 657 266 743 479 0 0 0 0 0 0 0 0
Totale 15.398